Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-852-1 | CAS number: 26628-22-8
Neurotoxicity
Administrative data
- Endpoint:
- neurotoxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
Data source
Referenceopen allclose all
- Reference Type:
- review article or handbook
- Title:
- Sodium azide
- Author:
- ACGIH (American Conference of Governmental Industrial Hygienists)
- Year:
- 1 991
- Bibliographic source:
- ISBN-13: 978-0936712963, Documentation of the Threshold Limit Values & Biological Exposure Indices, 6th ed, 1403-7
- Reference Type:
- publication
- Title:
- Brain metabolism in vivo. II. The distribution of lesions caused by azide, malononitrile, plasmocid and dinitrophenol poisoning in rats.
- Author:
- Hicks S.P.
- Year:
- 1 950
- Bibliographic source:
- AMA Arch Pathol. 50(5):545-61.
Materials and methods
Test material
- Reference substance name:
- Sodium azide
- EC Number:
- 247-852-1
- EC Name:
- Sodium azide
- Cas Number:
- 26628-22-8
- Molecular formula:
- N3Na
- IUPAC Name:
- sodium azide
Constituent 1
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- For more details see "details on results" section below
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- For more details see "details on results" section below
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- For more details see "details on results" section below
- Details on results:
- Repeated i.p. injections in rats of 5-10 mg/kg resulted in severe intoxication, with survivors showing demyelination of the nerve fibres of the CNS but no damage to the liver or kidney.
Applicant's summary and conclusion
- Conclusions:
- Repeated i.p. injections in rats of 5-10 mg/kg resulted in severe intoxication, with survivors showing demyelination of the nerve fibres of the CNS but no damage to the liver or kidney.
- Executive summary:
In a study cited from Hicks S.P. (1950), repeated i.p. injections in rats of 5-10 mg/kg resulted in severe intoxication, with survivors showing demyelination of the nerve fibres of the CNS but no damage to the liver or kidney.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
